Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

University Spinout Companies Explained: Definition and Formation Process

What a university spinout actually is, how it differs from an ordinary startup or a straight licensing deal, and the formation process from invention disclosure through incorporation, licensing, and initial funding.

A university spinout (also written spin-out, and closely related to but not always synonymous with a corporate “spin-off” — see Spin-out vs. Spin-off for that terminology distinction) is a new company formed specifically to commercialize research, intellectual property (IP), or know-how that originated inside a university, research institute, hospital, or other public research organisation. What makes it a spinout, rather than just another startup, is where the company’s core technology comes from and how it gets there: the origin institution’s technology transfer office (TTO) licenses or assigns that IP into the new company, and in exchange the institution typically takes an equity stake, a royalty interest, or both, negotiated as part of the deal. This guide is the foundational explainer for that whole area of the site: what a spinout actually is, how it differs from an ordinary startup or a plain licensing deal, and — in outline — the formation process a TTO and its academic founders walk through to get from an invention disclosure to an incorporated, funded company. Each step below links out to CASRAI’s dedicated, deeper guide on that specific stage.

What makes a company a “spinout”

Three features, together, are what distinguish a spinout from any other new company:

  • The core technology originates from institutional research. The founding IP — a patent, a body of know-how, software, or materials — was developed using the university’s resources, typically by faculty, postdocs, or students, and is owned or co-owned by the institution under its IP policy (in the US, this ownership default traces back to the Bayh-Dole Act, which lets universities elect to retain title to inventions made with federal funding rather than assigning that title to the government).
  • The TTO is a party to the deal. The new company doesn’t simply use the technology informally; it holds a formal license (usually exclusive, at least in the founding field of use) or an assignment from the institution, negotiated and administered by the TTO. See The Technology Transfer Process for how that office’s work more broadly moves an invention from disclosure to a signed deal.
  • The institution retains an ongoing interest. Almost always this means founder-stage equity in the new company, a running royalty on the license, or both — see University Spinout Equity Split for how that initial stake gets set.

Spinout vs. ordinary startup

Every spinout is a startup, but not every startup founded by a professor or graduate is a spinout. A faculty member who leaves to build a company around an idea with no underlying university-owned IP, no TTO-negotiated license, and no institutional equity or royalty stake has founded an ordinary startup — the university has no formal claim on it. The dividing line is the IP and the license, not simply who the founders are or where they used to work.

Spinout vs. a straight licensing deal

Licensing and spinout formation are two different paths a TTO can take with the same disclosed invention, not two names for the same thing. In a straight license, the TTO licenses the technology to an existing, already-operating company — no new entity is created, and the university typically receives an upfront fee and/or running royalties rather than equity. Spinout formation is the path taken when no existing licensee is a good fit — often because the technology is early-stage, platform-level, or requires the inventor’s continued involvement to develop further — so a new company is built around it instead, usually with the inventor(s) as founders. How Tech Transfer Offices Evaluate and Price a License covers how that licensing path works when it’s the one chosen.

The spinout formation process

Real TTOs rarely run these stages as a strict, one-directional sequence — equity negotiation and initial funding conversations often overlap, and a disclosure can sit for months awaiting a publication decision or a co-inventor’s sign-off. But the underlying path is consistent across most institutional policies and professional guidance from AUTM (the Association of University Technology Managers), the trade association for the field.

1. Invention disclosure

Formation starts the same way any technology-transfer case does: a researcher files an invention disclosure with the TTO, describing what was discovered, who contributed, and when — before any public talk, poster, or paper, since public disclosure can start the clock on statutory bars to patentability. See Invention Disclosure: What Researchers Submit to a TTO, and Why Timing Matters.

2. Patentability and commercial assessment

The TTO screens the disclosure for inventorship, prior art, and commercial potential, and starts forming a view on the best commercialization path — license to an existing company, or spin out a new one. See Patentability Assessment: How a TTO Evaluates an Invention Disclosure.

3. The decision to spin out

Where the assessment points toward spinout formation rather than licensing to an existing company — because the technology is platform-level, pre-commercial, or the inventor is committed to building the company themselves — the TTO and inventor(s) begin working toward incorporation. A faculty founder taking an operational or equity role in a company licensing university IP triggers a formal conflict-of-interest review at most institutions; see Faculty Conflict of Interest in Startups: A Disclosure Guide.

4. Incorporating the new company

The founders (typically the inventor(s), sometimes joined by a non-academic co-founder or early CEO) incorporate a new legal entity — commonly a Delaware C-corporation in the US, or a private limited company in the UK — before or alongside the license negotiation, since the license needs a counterparty to be signed with.

5. Negotiating the IP license or assignment

The TTO negotiates an exclusive license (or, less commonly, an assignment) of the founding IP to the newly incorporated company, covering scope, field of use, diligence milestones the company must meet to keep the license, and the consideration the university receives. See License Agreement Structure and the License Agreement dictionary entry.

6. Setting the founding equity split

In the same window, the university and founders negotiate what percentage of the company’s founding share capital the institution takes as part or all of its license consideration, and how the founders’ share is divided among themselves. This is a large enough topic to warrant its own guide: University Spinout Equity Split: How Founders and TTOs Set the Initial Stake.

7. Initial capitalization

Once formed, the company still needs money to operate — non-dilutive federal awards (SBIR/STTR), university gap or proof-of-concept funds, and dilutive angel or venture capital are the main instruments, each with different conflict-of-interest and Bayh-Dole considerations. See Funding Options for a University Spinout and Entrepreneurial Resources for University Spinouts and Faculty Founders for the non-financial support layer (incubators, EIR programs, mentor networks) alongside it.

8. Ongoing TTO involvement

Formation isn’t the end of the institution’s role. The TTO typically monitors the license’s diligence milestones, may hold a board observer seat tied to its equity stake, and — for federally funded inventions — continues tracking Bayh-Dole utilization reporting obligations for the life of the patent.

How long formation typically takes

There’s no fixed timeline, and institutions and AUTM’s own published surveys don’t report a single standard figure — the path from a promising invention disclosure to a fully incorporated, licensed, and initially funded spinout is commonly reported to take anywhere from several months to a couple of years, depending heavily on how far along the technology is, how quickly a founding team and initial funding come together, and how much negotiation the license and equity terms require. Treat any more specific figure with caution unless it’s sourced to a specific institution’s own reporting.

What happens after formation

Once a spinout is capitalized and operating, the university’s stake doesn’t stay static. Each further financing round dilutes both the university’s and the founders’ percentage ownership — see Equity Dilution for Academic Founders for that mechanic — and the company eventually reaches some form of outcome: acquisition, IPO, or wind-down, each of which affects the university’s equity differently. See Exit Strategies for University Spinout Companies.

Frequently asked questions

Is a university spinout the same thing as a startup?

A spinout is a specific kind of startup — one built around IP licensed or assigned from a university’s TTO, with the institution typically retaining equity, a royalty, or both. A startup founded without any university-owned IP or TTO involvement is not a spinout, even if the founder is a current or former academic.

Does the university own the spinout company?

No — the university is typically a minority shareholder (commonly a low-single-digit to roughly 10% stake in US practice, though founding equity practice varies significantly by country and institution) and/or a licensor receiving royalties, not the owner or operator of the company. Founders and, later, outside investors hold the majority of the equity and run the business.

What’s the difference between a “spin-out” and a “spin-off”?

The terms are inconsistently used, but the most common convention — particularly in UK research administration — reserves “spin-out” for a company built on university/research-institute IP, and “spin-off” for a company an existing operating business separates out from one of its own divisions, with no university or TTO involved. See Spin-out vs. Spin-off — What Is the Difference? for the full comparison.

Who decides whether an invention becomes a license or a spinout?

The TTO makes that recommendation, based on its patentability and commercial assessment of the disclosure, usually in consultation with the inventor(s) — factors include whether an existing company is a credible licensee, how early-stage the technology is, and whether an inventor is committed to founding and running a company around it.

Does forming a spinout require a patent?

Not always — some spinouts are built around know-how, software, materials, or trade secrets rather than a granted patent, though a filed or pending patent application is common where patentable subject matter exists, since it’s usually central to what the company is licensing.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →